Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Chest ; 157(1): e1-e3, 2020 01.
Article in English | MEDLINE | ID: mdl-31916968

ABSTRACT

CASE PRESENTATION: A 38-year-old male with a prior diagnosis of severe OSA (apnea-hypopnea index [AHI] 99/h) presented for transfer of care. He was successfully titrated to CPAP of 10 cm H2O at an outside laboratory and was compliant with therapy with residual AHI 1.9/h. On presentation, he was polycythemic, with negative evaluation for primary polycythemia, and evaluation for hypoxemia was initiated.


Subject(s)
Continuous Positive Airway Pressure , Sleep Apnea, Obstructive/therapy , Adult , Humans , Hypoxia , Male , Polysomnography , Severity of Illness Index
2.
Vaccine ; 36(45): 6606-6614, 2018 10 29.
Article in English | MEDLINE | ID: mdl-30314912

ABSTRACT

Cholera, a diarrheal disease primarily affecting vulnerable populations in developing countries, is estimated to cause disease in more than 2.5 million people and kill almost 100,000 annually. An oral cholera vaccine (OCV) has been available globally since 2001; the demand for this vaccine from affected countries has however been very low, due to various factors including vaccine price and mode of administration. The low demand for the vaccine and limited commercial incentives to invest in research and development of vaccines for developing country markets has kept the global supply of OCVs down. Since 1999, the International Vaccine Institute has been committed to make safe, effective and affordable OCVs accessible. Through a variety of partnerships with collaborators in Sweden, Vietnam, India and South Korea, and with public and private funding, IVI facilitated development and production of two affordable and WHO-prequalified OCVs and together with other stakeholders accelerated the introduction of these vaccines for the global public-sector market.


Subject(s)
Cholera Vaccines/supply & distribution , Cholera/immunology , Cholera/prevention & control , Public-Private Sector Partnerships , Administration, Oral , Cholera Vaccines/administration & dosage , Cholera Vaccines/therapeutic use , India , Republic of Korea , Sweden , Vietnam
3.
J Clin Invest ; 128(12): 5561-5572, 2018 12 03.
Article in English | MEDLINE | ID: mdl-30226828

ABSTRACT

Heart failure (HF) remains a major source of morbidity and mortality in the US. The multifunctional Ca2+/calmodulin-dependent kinase II (CaMKII) has emerged as a critical regulator of cardiac hypertrophy and failure, although the mechanisms remain unclear. Previous studies have established that the cytoskeletal protein ßIV-spectrin coordinates local CaMKII signaling. Here, we sought to determine the role of a spectrin-CaMKII complex in maladaptive remodeling in HF. Chronic pressure overload (6 weeks of transaortic constriction [TAC]) induced a decrease in cardiac function in WT mice but not in animals expressing truncated ßIV-spectrin lacking spectrin-CaMKII interaction (qv3J mice). Underlying the observed differences in function was an unexpected differential regulation of STAT3-related genes in qv3J TAC hearts. In vitro experiments demonstrated that ßIV-spectrin serves as a target for CaMKII phosphorylation, which regulates its stability. Cardiac-specific ßIV-spectrin-KO (ßIV-cKO) mice showed STAT3 dysregulation, fibrosis, and decreased cardiac function at baseline, similar to what was observed with TAC in WT mice. STAT3 inhibition restored normal cardiac structure and function in ßIV-cKO and WT TAC hearts. Our studies identify a spectrin-based complex essential for regulation of the cardiac response to chronic pressure overload. We anticipate that strategies targeting the new spectrin-based "statosome" will be effective at suppressing maladaptive remodeling in response to chronic stress.


Subject(s)
Cardiomegaly/metabolism , Heart Failure/metabolism , STAT3 Transcription Factor/metabolism , Signal Transduction , Spectrin/metabolism , Animals , Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics , Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism , Cardiomegaly/genetics , Cardiomegaly/pathology , Fibrosis , Heart Failure/genetics , Heart Failure/pathology , Mice , Mice, Transgenic , Phosphorylation , STAT3 Transcription Factor/genetics , Spectrin/genetics
4.
Nat Med ; 14(12): 1363-9, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19029982

ABSTRACT

Fibrodysplasia ossificans progressiva (FOP) is a congenital disorder of progressive and widespread postnatal ossification of soft tissues and is without known effective treatments. Affected individuals harbor conserved mutations in the ACVR1 gene that are thought to cause constitutive activation of the bone morphogenetic protein (BMP) type I receptor, activin receptor-like kinase-2 (ALK2). Here we show that intramuscular expression in the mouse of an inducible transgene encoding constitutively active ALK2 (caALK2), resulting from a glutamine to aspartic acid change at amino acid position 207, leads to ectopic endochondral bone formation, joint fusion and functional impairment, thus phenocopying key aspects of human FOP. A selective inhibitor of BMP type I receptor kinases, LDN-193189 (ref. 6), inhibits activation of the BMP signaling effectors SMAD1, SMAD5 and SMAD8 in tissues expressing caALK2 induced by adenovirus specifying Cre (Ad.Cre). This treatment resulted in a reduction in ectopic ossification and functional impairment. In contrast to localized induction of caALK2 by Ad.Cre (which entails inflammation), global postnatal expression of caALK2 (induced without the use of Ad.Cre and thus without inflammation) does not lead to ectopic ossification. However, if in this context an inflammatory stimulus was provided with a control adenovirus, ectopic bone formation was induced. Like LDN-193189, corticosteroid inhibits ossification in Ad.Cre-injected mutant mice, suggesting caALK2 expression and an inflammatory milieu are both required for the development of ectopic ossification in this model. These results support the role of dysregulated ALK2 kinase activity in the pathogenesis of FOP and suggest that small molecule inhibition of BMP type I receptor activity may be useful in treating FOP and heterotopic ossification syndromes associated with excessive BMP signaling.


Subject(s)
Bone Morphogenetic Protein Receptors, Type I/antagonists & inhibitors , Ossification, Heterotopic/drug therapy , Ossification, Heterotopic/metabolism , Animals , Bone Morphogenetic Protein Receptors, Type I/metabolism , Cell Line , Disease Models, Animal , Mice , Mice, Inbred C57BL , Molecular Structure , Myositis Ossificans/genetics , Myositis Ossificans/metabolism , Myositis Ossificans/pathology , Ossification, Heterotopic/genetics , Ossification, Heterotopic/pathology , Pyrazoles/chemistry , Pyrazoles/therapeutic use , Pyrimidines/chemistry , Pyrimidines/therapeutic use , Signal Transduction/drug effects , Tomography, X-Ray Computed
5.
Acta Pharmacol Sin ; 29(9): 1137-40, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18718183

ABSTRACT

AIM: Panax notoginseng is a cultivated ginseng species highly valued for its various pharmacological activities mostly associated with triterpenoid saponin glycosides. It would be of great interest to understand biodiversity in this ginseng species after its long history of domestication. METHODS: We collected 92 random sampled 3-year-old P notoginseng plants from 4 counties of Wenshan prefecture in Yunnan province, China and documented their morphological features of plant height, stem color, number of leaves/leaflets and dry weight of tap root. Their genetic diversity was evaluated by fluorescent amplified fragment length polymorphism (fAFLP) analysis. RESULTS: Among the samples collected, variable morphological features were observed. For these 4 populations (Zhulijie, Shangliuhe, Bazai and Jinbuhuan) analyzed by fAFLP, percentage of polymorphic bands among the total number of 582 discrete bands were 74.05%, 45.36%, 38.83% and 51.89% respectively. Mean genetic heterozygosity were 0.166, 0.093, 0.094 and 0.125. On the other hand, Nei genetic distances among populations were all <0.03. Further analysis of molecular variance (AMOVA) attributed most (93.5%) genetic diversity to within population variation. Principal coordinates analysis (PCA) did not group any population distinctively. CONCLUSION: This domesticated ginseng species still maintains a fair level of biodiversity and this conclusion is consistent with the local practice of non-selective collection of seeds for next season planting. There was no genetic drift in populations. Biodiversity of P notoginseng can be exploited to improve this important herb through breeding. Two possible strategies include inbreeding for pure lines and hybrid breeding with genetic divergent parents for hybrid vigor.


Subject(s)
Panax notoginseng/chemistry , Panax notoginseng/genetics , Amplified Fragment Length Polymorphism Analysis , Analysis of Variance , Biodiversity , DNA, Plant/biosynthesis , DNA, Plant/genetics , Panax notoginseng/anatomy & histology , Plant Leaves/chemistry
6.
Phytochemistry ; 68(10): 1448-58, 2007 May.
Article in English | MEDLINE | ID: mdl-17434191

ABSTRACT

To understand the factors contributing to estrogenic properties of extracts from the genus Epimedium L. (Berberidaceae), we performed taxonomic, genetic and chemical characterization on 37 specimens from 18 species and related these to estrogen receptor (ERalpha and ERbeta) bioactivity, as measured by reporter genes in stable human cells. Boot strap values derived from amplified fragment length polymorphisms indicated that specimens of E. koreanum, E. brevicornum, E. myrianthum, E. leishanense, and E. membranaceum were genetically distinct and this was supported by their very similar ERalpha activities. In contrast, specimens from E. pubescens and E. sagittatum were diverse both genetically, chemically and in terms of ERalpha and ERbeta bioactivities. Strikingly, a genetic cluster comprising six rare Epimedium species exhibited strongest ERalpha and ERbeta activity, and this bioactivity was positively correlated with content of trace flavonoid aglycones (kaempferol, apigenin, quercetin, luteolin and breviflavone B). In contrast, there was no association between estrogenic activity and the major flavonol glycoside constituents (icariin and epimedin A-C). Although they exhibited equally strong ERalpha and ERbeta activity, E. koreanum can be clearly differentiated from E. pubescens and E. brevicornum by genetic distance and its significantly lower content of epimedin C. Our morphologic, genetic, chemical and bioactivity profiling provide the basis for the production of extracts with reproducible estrogenic properties. Such reproducibility will be critical for the standardization of Epimedium-based products.


Subject(s)
Drugs, Chinese Herbal/pharmacology , Epimedium/chemistry , Phytoestrogens/pharmacology , Cells, Cultured , Drugs, Chinese Herbal/chemistry , Drugs, Chinese Herbal/isolation & purification , Epimedium/classification , Epimedium/genetics , Estrogen Receptor alpha/chemistry , Estrogen Receptor beta/chemistry , Flavonols/chemistry , Flavonols/isolation & purification , Genes, Reporter , Humans , Phylogeny , Phytoestrogens/chemistry , Phytoestrogens/isolation & purification , Polymorphism, Genetic
7.
J Agric Food Chem ; 53(22): 8460-7, 2005 Nov 02.
Article in English | MEDLINE | ID: mdl-16248538

ABSTRACT

Radix notoginseng, the root of Panax notoginseng (Burk.) F. H. Chen, has been widely used in traditional Chinese medicine. Its main components, saponins, have been reported to have many pharmacological activities. To test the general assumption that herbs of a single species planted and harvested from a single location are uniform in chemical and genetic makeup, chemical analysis and DNA fingerprinting were carried out. High-performance TLC together with HPLC analysis were used to analyze 17 randomly sampled 3-year-old roots from a single farm for the presence of six saponins. Five roots showed distinct chemical profiles with changed ratios of ginsenosides Rd/Rg1, Re/Rg1, or Rb1/Rg1. The same samples, together with some 1- and 2-year-old samples, were also subjected to fluorescent amplified fragment length polymorphism (AFLP) analysis, and their internal transcribed spacer 2 (ITS 2) regions were sequenced. Fluorescent AFLP analysis was found to be much more polymorphic than the ITS 2 sequence and showed clear evidence of genetic diversity within the tested population. In conclusion, genetic diversity and variation of saponin contents between individual P. notoginseng roots have been detected. We suggest that genetic diversity affects the contents of the six saponins. The saponin contents variation and genetic diversity were also found among P. notoginseng root samples collected from China and Singapore markets. Since variable saponin contents may affect therapeutic efficacy, combining the use of genetic profiling with chemical profiling will help ensure greater uniformity in the quality of P. notoginseng roots. The genetic and chemical diversity within a population also provides the opportunity for breeding new cultivars with more desirable chemical constituents.


Subject(s)
Genetic Variation , Panax/chemistry , Panax/genetics , Plant Roots/chemistry , Saponins/analysis , Base Sequence , Chromatography, High Pressure Liquid , DNA, Plant/analysis , DNA, Plant/chemistry , Phylogeny , Sequence Alignment
SELECTION OF CITATIONS
SEARCH DETAIL
...